Watch KOD. Know when insiders buy.
One email the day a filing lands. Free.
KOD
Kodiak Sciences Inc.
98.89
+1.26 +1.29%
USD · close Nov 3
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
60
WATCH · insiders 80, shorts 39
Insiders, 90 days
+$154.3M
net buying · 82 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $6.2BP/E —DIV YIELD —FCF YIELD -2.57%REV TTM —NET INCOME −$242MNET CASH —52W 16.90 – 100.40NEXT EARNINGS Nov 12 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$66.8M | −$65.6M | — | -1.05 | −$46.2M | $352K | −$46.6M | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$59.8M | −$58.2M | — | -0.94 | −$40M | $942K | −$41M | Aug 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$57.5M | −$56.7M | — | -1.04 | −$39.4M | $43K | −$39.4M | Mar 31 |
| Q3 2025 · Sep 30 | — | — | — | −$62.4M | −$61.5M | — | -1.16 | −$32.9M | $60K | −$32.9M | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$55.5M | −$54.3M | — | -1.03 | −$34.7M | $133K | −$34.8M | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$59.1M | −$57.5M | — | -1.09 | −$29.1M | $270K | −$29.3M | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$46.2M | −$44.1M | — | -0.84 | −$30.1M | $124K | −$30.2M | Mar 31 |
| Q3 2024 · Sep 30 | — | — | — | −$46.6M | −$43.9M | — | -0.84 | −$21.2M | $180K | −$21.3M | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$48M | −$45.1M | — | -0.86 | −$26.5M | $49K | −$26.5M | Nov 13 |
| Q1 2024 · Mar 31 | — | — | — | −$46.1M | −$43M | — | -0.82 | −$39.6M | $22K | −$39.6M | Nov 13 |
| Q4 2023 · Dec 31derived | — | — | — | −$63.4M | −$59.5M | — | -1.13 | −$32.2M | $27.5M | −$59.7M | Mar 31 |
| Q3 2023 · Sep 30 | — | — | — | −$54.5M | −$50M | — | -0.95 | −$32.8M | $226K | −$33M | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$234.4M | −$230M | — | -4.32 | −$136M | $506K | −$136.5M | — | — |
| FY2024 · to Dec 31 | — | — | −$186.8M | −$176.2M | — | -3.35 | −$117.3M | $375K | −$117.7M | — | — |
| FY2023 · to Dec 31 | — | — | −$277.3M | −$260.5M | — | -4.97 | −$154.2M | $41.4M | −$195.5M | — | — |
| FY2022 · to Dec 31 | — | — | −$341.4M | −$333.8M | — | -6.39 | −$206.5M | $37M | −$243.5M | — | — |
| FY2021 · to Dec 31 | — | — | −$267.1M | −$267M | — | -5.16 | −$182.3M | $17M | −$199.3M | — | — |
| FY2020 · to Dec 31 | — | — | −$136M | −$133.1M | — | -2.91 | −$83.4M | $3.8M | −$87.2M | — | — |
Every number comes from Kodiak Sciences Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.